Ruxolitinib Phosphate and Dasatinib or Nilotinib in Treating Patients With Chronic
How well does ruxolitinib phosphate and dasatinib or nilotinib work in treating patients
with chronic myeloid leukemia?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This randomized phase II trial studies how well ruxolitinib phosphate and dasatinib
or nilotinib work in treating patients with chronic myeloid leukemia. Ruxolitinib,
dasatinib, and nilotinib may stop the growth of cancer cells by blocking some of the
enzymes needed for cell growth.
Study Reference #: cleu19017
Lead Researcher (Principal Investigator)
Lead Researcher: Kristen O'Dwyer
Study Contact InformationStudy Coordinator: Haley Misch
Phone: (585) 275-9485
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search